Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Biomedical Reports|April 22, 2014
Targeting regulatory T cells in cytokine-induced killer cell cultures (Review)Qianshan Tao, Huiping Wang, Zhimin ZhaiTransfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|February 5, 2024
Quartic CAR-T Cell Bridging to Twice Allo-HSCT Therapy in a Patient with Acute Lymphoblastic LeukemiaQing Zhang, Yi Dong, Zhimin Zhai, et al.Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|December 23, 2023
[miR-181b-5p promotes cell proliferation and induces apoptosis in human acute myeloid leukemia by targeting PAX9]Bin Li, Qianshan Tao, Xueying Hu, et al.Medicine|November 7, 2023
Cladribine, cytarabine, and filgrastim based regimen in relapsed or refractory acute myeloid leukemia: A systematic review and meta-analysisSusu Cao, Qianshan Tao, Jia Wang, et al.Acta Haematologica|February 15, 2024
Lenalidomide Treatment of Isolated Central Nervous System Relapse in Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell TherapyQing Zhang, Yi Dong, Zhimin Zhai, et al.Journal of Clinical Medicine|April 30, 2021
Elevated M-MDSCs in Circulation Are Indicative of Poor Prognosis in Diffuse Large B-Cell Lymphoma PatientsZhitao Wang, Rui Jiang, Qian Li, et al.Heart and Vessels|October 5, 2017
Tumor necrosis factor alpha-stimulated gene-6 (TSG-6) inhibits the inflammatory response by inhibiting the activation of P38 and JNK signaling pathway and decreases the restenosis of vein grafts in ratsChengxin Zhang, Biao Zhang, Huiping Wang, et al.Clinical Laboratory|February 22, 2021
Isolated Central Nervous System Blast Crisis of Chronic Myeloid Leukemia with Dasatinib TherapyYi Dong, Jia Wang, Yuanyuan Shen, et al.Oncology Letters|June 18, 2016
Transverse myelopathy occurring with intrathecal administration of methotrexate and cytarabine chemotherapy: A case reportYing Pan, Chunhuai Wang, Huiping Wang, et al.Annals of Hematology|February 15, 2021
Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysisLinhui Hu, Alice Charwudzi, Qian Li, et al.Pageof 5